Literature DB >> 16907879

Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography.

C Male1, D Koren, B Eichelberger, K Kaufmann, S Panzer.   

Abstract

Patients with Glanzmann thrombasthenia (GT) may form isoantibodies which induce refractoriness or inhibition of function of transfused platelets. We monitored the survival and function of transfused platelets by flow cytometry and thrombelastography in a patient with GT. Gating on CD42a+ allowed identification of even a few transfused platelets. Only by gating on these CD41+ CD42a+ cells were we able to demonstrate their capability to bind fibrinogen and PAC-1 upon activation. Platelets were rapidly cleared from the circulation as a result of boosted isoantibodies. The contribution of transfused platelets to clot formation was also demonstrated by thrombelastography by blocking their function with abciximab.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907879     DOI: 10.1111/j.1423-0410.2006.00797.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-αIIbβ3 alloantibodies.

Authors:  Hirokazu Kashiwagi; Kazunobu Kiyomizu; Tsuyoshi Kamae; Tsuyoshi Nakazawa; Seiji Tadokoro; Shuji Takiguchi; Yuichiro Doki; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2010-12-08       Impact factor: 2.490

2.  Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders.

Authors:  Meera Chitlur; Madhvi Rajpurkar; Michael Recht; Michael D Tarantino; Donald L Yee; David L Cooper; Sriya Gunawardena
Journal:  Int J Gen Med       Date:  2017-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.